CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+6.67%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$2.14B
AUM Growth
+$2.14B
(+5%)
Cap. Flow
+$22.6M
Cap. Flow
% of AUM
1.06%
Top 10 Holdings %
Top 10 Hldgs %
54.69%
Holding
37
New
3
Increased
14
Reduced
4
Closed
5
Top Buys
| 1 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$59.7M |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$45.2M |
| 3 |
Viatris
VTRS
|
$45.2M |
| 4 |
Perrigo
PRGO
|
$38.3M |
| 5 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$35.5M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$79.1M |
| 2 |
SHPG
Shire pic
SHPG
|
$76M |
| 3 |
Tenet Healthcare
THC
|
$67.1M |
| 4 |
GSK
GSK
|
$58.6M |
| 5 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
$52.8M |
Sector Composition
| 1 | Healthcare | 83.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $168M | 6.45% | 1,005,000 +155,000 | +18% | +$25.8M |
|
2
HCA Healthcare
HCA
$94.5B
| $139M | 5.33% | 1,350,000 +100,000 | +8% | +$10.3M |
|
3
Biogen
BIIB
$19.4B
| $131M | 5.03% | 450,000 -65,000 | -13% | -$18.9M |
|
|
GHDX
4
DELISTED
Genomic Health, Inc.
GHDX
| $124M | 4.77% | 2,458,100 | – | – |
|
|
TSRO
5
DELISTED
TESARO, Inc.
TSRO
| $111M | 4.28% | 2,500,000 +775,000 | +45% | +$34.5M |
|
|
SHPG
6
DELISTED
Shire pic
SHPG
| $110M | 4.22% | 650,000 -450,000 | -41% | -$76M |
|
7
Universal Health Services
UHS
$11.6B
| $100M | 3.86% | 900,000 +120,000 | +15% | +$13.4M |
|
|
GBT
8
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $99.4M | 3.83% | 2,200,000 +1,000,000 | +83% | +$45.2M |
|
9
Nektar Therapeutics
NKTR
$568M
| $97.7M | 3.76% | 2,000,000 +500,000 | +33% | +$24.4M |
|
|
10
Viatris
VTRS
$12.3B
| $90.4M | 3.48% | 2,500,000 +1,250,000 | +100% | +$45.2M |
|
|
11
Tenet Healthcare
THC
$16.3B
| $75.5M | 2.91% | 2,250,000 -2,000,000 | -47% | -$67.1M |
|
|
MDCO
12
DELISTED
Medicines Co
MDCO
| $73.4M | 2.82% | 2,000,000 | – | – |
|
|
EVHC
13
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $72.6M | 2.79% | 1,650,000 -1,200,000 | -42% | -$52.8M |
|
|
14
Perrigo
PRGO
$3.27B
| $67.4M | 2.59% | 925,000 +525,000 | +131% | +$38.3M |
|
|
NUVA
15
DELISTED
NuVasive, Inc.
NUVA
| $62.5M | 2.41% | 1,200,000 | – | – |
|
|
MNTA
16
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $62.5M | 2.4% | 3,055,000 +2,919,700 | +2,158% | +$59.7M |
|
17
Atara Biotherapeutics
ATRA
$84.6M
| $59.5M | 2.29% | 1,620,000 +3,310 | +0.2% | +$122K |
|
18
Brookdale Senior Living
BKD
$1.83B
| $59.1M | 2.27% | 6,500,000 | – | – |
|
19
Myriad Genetics
MYGN
$593M
| $56.1M | 2.16% | 1,500,000 | – | – |
|
|
CSII
20
DELISTED
Cardiovascular Systems, Inc.
CSII
| $53.3M | 2.05% | 1,647,677 +411,317 | +33% | +$13.3M |
|
|
ELGX
21
DELISTED
Endologix Inc
ELGX
| $52.6M | 2.03% | 9,300,000 | – | – |
|
|
AMAG
22
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $51.7M | 1.99% | 2,650,000 | – | – |
|
|
CLVS
23
DELISTED
Clovis Oncology, Inc.
CLVS
| $45.5M | 1.75% | 1,000,000 +175,000 | +21% | +$7.96M |
|
|
KTWO
24
DELISTED
K2M Group Holdings, Inc
KTWO
| $45M | 1.73% | 2,000,000 +650,677 | +48% | +$14.6M |
|
|
MNK
25
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $35.5M | 1.36% | +1,900,000 | New | +$35.5M |
|